Vertex Pharmaceuticals Contract with Customer, Liability increased by 27.3% to $218.70M in Q1 2026 compared to the prior quarter. This is a positive signal — higher values indicate stronger performance for this metric.
An increase often signals strong future revenue visibility, while a decrease may indicate the fulfillment of service obligations.
This represents the obligation to transfer services to a customer for which the entity has received consideration or for...
Common in businesses with subscription or recurring service models where upfront payments are standard.
other_contract_with_customer_liability| Q4 '25 | Q1 '26 | |
|---|---|---|
| Value | $171.80M | $218.70M |
| QoQ Change | — | +27.3% |